You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Poly I-C

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post COVID-19 Condition, Long COVID Trial (Rintatolimod, Placebo / Normal Saline)

Not yet recruiting
  • Post COVID-19 Condition
  • Long COVID
  • (no location specified)
Oct 20, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Chronic Fatigue Syndrome Trial in Incline Village, Charlotte (Poly I: Poly C12U (Rintatolimod))

Available
  • Chronic Fatigue Syndrome
  • Poly I: Poly C12U (Rintatolimod)
  • Incline Village, Nevada
  • +1 more
Apr 29, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Allergic Rhinitis, Asthma, Latent Tuberculosis Trial in Paddington (Poly ICLC, Poly I:C, R848)

Completed
Has Results
  • Allergic Rhinitis
  • +2 more
  • Poly ICLC
  • +5 more
  • Paddington, London, United Kingdom
    Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's H
Nov 3, 2021

Recurrent Glioblastoma Trial in Los Angeles (biological, other, drug)

Recruiting
  • Recurrent Glioblastoma
  • Dendritic Cell Tumor Cell Lysate Vaccine
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 29, 2022

Pancreatic Cancer Trial (Rintatolimod)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Aug 8, 2022

Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Diffuse Hemispheric Glioma, H3 G34-Mutant
  • Dendritic Cell Tumor Peptide Vaccine
  • +6 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2021

Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +2 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2021

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +5 more
  • Tucson, Arizona
  • +16 more
Oct 19, 2022

Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

Recruiting
  • Leiomyosarcoma
  • +29 more
  • Definitive Surgical Resection
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022

Glioblastoma Multiforme, Glioblastoma, Adult, Glioma of Brain Trial in Geneva (IMA950/Poly-ICLC, IMA950/Poly-ICLC and

Active, not recruiting
  • Glioblastoma Multiforme
  • +3 more
  • Geneva, Switzerland
    University Hospitals of Geneva
Dec 23, 2022

Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

Completed
Has Results
  • Cutaneous Melanoma
  • +11 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +2 more
  • Chicago, Illinois
  • +6 more
Nov 10, 2021

Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

Completed
  • Prostate Cancer
  • Intratumoral (IT) Poly ICLC 0.5 mg
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 8, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Orange, California
  • +15 more
Aug 23, 2022

Retention Trial in Cairo (CAD PEEK frame-work)

Not yet recruiting
  • Retention
  • CAD PEEK frame-work
  • Cairo, Manial, Egypt
    Faculty of Dentistry
Jan 2, 2023

Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep

Recruiting
  • Glioma, Malignant
  • +2 more
  • NeoPep Vaccine1 plus Poly-ICLC
  • NeoPep Vaccine2 plus Poly-ICLC
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 7, 2022

COVID - 19 Trial in Calgary (Poly-ICLC (Hiltonol®) or Placebo)

Recruiting
  • COVID - 19
  • Poly-ICLC (Hiltonol®) or Placebo
  • Calgary, Alberta, Canada
    Health Research Innovation Centre
Mar 31, 2022

Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

Active, not recruiting
  • Ovarian Neoplasms
  • +2 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • Brussels, Belgium
  • +4 more
Dec 19, 2022

Metastatic Cancer Trial in London (Stereotactic ablative radiotherapy - Level 1, Stereotactic ablative radiotherapy - Level 2,

Recruiting
  • Metastatic Cancer
  • Stereotactic ablative radiotherapy - Level 1
  • +4 more
  • London, Ontario, Canada
    London Health Sciences Centre - London Regional Cancer Program
Apr 4, 2022

Hepatocellular Carcinoma Trial in Taipei City (Poly ICLC)

Recruiting
  • Hepatocellular Carcinoma
  • Poly ICLC
  • Taipei City, Zhongzheng Dist, Taiwan
    NTUH
Mar 7, 2022

Glaucoma Trial in Sohag (Ahmed Valve)

Recruiting
  • Glaucoma
  • Ahmed Valve
  • Sohag, Egypt
    Sohag University
Mar 26, 2022

Unresectable or Metastatic Melanoma Trial in Australia, United States (Ipilimumab, NY-ESO-1 Protein Vaccine, NY-ESO-1 OLP4

Terminated
Has Results
  • Unresectable or Metastatic Melanoma
  • Ipilimumab
  • +3 more
  • New York, New York
  • +4 more
Oct 3, 2022